Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs
2 sources·Updated September 29, 2026
Covered by 2 sources
- Ars Technica·13h agoMost powerful obesity drug yet: People lost up to 25% of weight in trial
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Read at Ars Technica → - Scientific American·13h agoBlockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs
The experimental weight-loss drug is a triple agonist and the first of its kind to reach a phase 3 clinical trial
Read at Scientific American →
